The leading market experts have placed a mean price target of $30.50 on Vitamin Shoppe, Inc (NYSE:VSI) stock. This price level, which is estimated to be attained in one-year, indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.45 a share for the upcoming quarter and $2.17 for the current fiscal.
The technical analysis of Vitamin Shoppe, Inc Common Stoc plainly substantiates that the 50-day moving average of Vitamin Shoppe, Inc Common Stoc is $29.76, and stock is trading $-3.47 points away or -11.65% from its 50-day moving average of $29.76. Further it is trading $-3.45 or -11.59% away its 200-day moving average of $29.74. Vitamin Shoppe, Inc (NYSE:VSI) 52-week high is $36.39 and the 52-week low is $26.02.
This explains if the stock moves $-10.10, it will post a 52-week high. In event of +1.04% decline, a 52-week low will be hit.
Taking the valuation aspect to emphasize the valuation of Vitamin Shoppe, Inc Common Stoc, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Vitamin Shoppe, Inc (NYSE:VSI) ratio came in at 15.40.
The stock last ended the trading session at $26.29 and registered a market cap of $620.02M. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Vitamin Shoppe, Inc (NYSE:VSI) PEG ratio is at 2.09.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...